Sermorelin vs. tesamorelin vs. CJC-1295/ipamorelin: how growth hormone peptides compare
By Alison Malizzi, MSN, AGACNP-BC · October 15, 2026
Growth hormone (GH) declines with age, and lower GH is linked to more body fat, less muscle, and poorer sleep and recovery. Rather than giving GH itself, growth hormone–releasing peptides prompt your pituitary gland to release more of its own, in a more natural pulse. People use them for deeper, more restful sleep, faster recovery from workouts and injuries, increased lean muscle mass, less body fat (especially around the belly), and better energy and skin. Here's how the most-discussed options compare.
The two ways these peptides work
- GHRH analogs (sermorelin, tesamorelin, CJC-1295) copy growth hormone–releasing hormone, the brain's main "release GH" signal.
- GH secretagogues (ipamorelin) act on a different receptor, the ghrelin receptor, to trigger GH release. That's why ipamorelin is often paired with a GHRH analog.
Sermorelin
Sermorelin is a short version of natural GHRH. It was FDA-approved in the past for children with GH deficiency and was later discontinued by the manufacturer for business reasons, not safety. It's short-acting, usually given as a nightly injection, and is available through compounding pharmacies. It has the longest track record of the group, though studies in healthy adults for anti-aging are small.
Tesamorelin
Tesamorelin is a modified GHRH and is FDA-approved for certain conditions. It has the strongest clinical trial data of these peptides, particularly for visceral (belly) fat. Use for other purposes is off-label. In real life, people use it to lose stubborn belly fat, increase lean muscle mass, improve body composition, and support energy and recovery.
CJC-1295 and ipamorelin
CJC-1295 is a longer-acting GHRH analog, and ipamorelin is a selective secretagogue; the two are commonly combined. People most often report deeper sleep, faster recovery, gains in lean muscle, less body fat, and better energy and skin over a few months. Neither is FDA-approved, and availability depends on current FDA compounding rules, so we review your options at your consultation.
At a glance
| Sermorelin | Tesamorelin | CJC-1295 / ipamorelin | |
|---|---|---|---|
| Type | GHRH analog | GHRH analog | GHRH analog + secretagogue |
| FDA status | Previously approved; compounded | FDA-approved (Egrifta) | Not FDA-approved; availability depends on FDA compounding rules |
| Strongest evidence | GH deficiency (children) | Visceral fat reduction | Limited |
Safety and monitoring
Possible side effects include injection-site reactions, flushing, headache, water retention, joint aches, and changes in blood sugar. Because GH and IGF-1 promote cell growth, these peptides aren't used in people with active cancer, and IGF-1 and glucose should be monitored. Long-term effects in healthy adults aren't well studied.
Is a GH peptide right for you?
Sleep, strength training, protein intake, and metabolic health come first, and peptides may add to that foundation. A peptide consultation at Vida Avanti reviews your goals and labs, explains which options are legally available, and discusses evidence, risks, and cost before you decide.
This article is for general education and isn't medical advice. Talk with a licensed clinician about your own situation.
Ready to feel like yourself again?
Start with a telehealth consultation. Your labs are done before your visit, so we can review results and build your plan in one conversation.
Book a consultation